As expected, USP22 expression was associated with the Ki67 proliferation index marker within the group of primary tumor biopsies (Fig. 2G) and was increasingly expressed in all lymph node metastases (Fig. 2H), strongly pointing to a profound role of this DUB in the progression and metastatic dissemination of this disease. Here, USP22 is linked to neoplasm.